DNM1L and hepatocellular carcinoma: Thus, the Drp1-specific inhibitor, Mdivi-1, targets mitochondrial autophagy, upregulates Bax and downregulates Bcl-xL, increases mitochondrial membrane permeability, and stimulates cytochrome c release, thereby increasing cisplatin-induced apoptosis in HCC (66).